Experiences of patient and care partner dyads in early Alzheimer's disease: a mixed-method study in the United States [0.03%]
美国早发型阿尔茨海默病患者及其照护伙伴的共同体验：一项混合研究方法研究
Lei Lv,Elnara Fazio-Eynullayeva,Paul Mystkowski et al.
Lei Lv et al.
Aims: Understanding the holistic experience of patients with early Alzheimer's disease (AD) and their care partners is important to identify unmet needs. This study aimed to describe and compare patient-care partner dyad ...
Francesca Bosinelli,Andrea Brugnolo,Nicola Girtler et al.
Francesca Bosinelli et al.
Correction [0.03%]
改正通知书
Published Erratum
Neurodegenerative disease management. 2025 Aug 3:1. DOI:10.1080/17582024.2025.2543158 2025
A drug evaluation narrative review of cladribine as a treatment for multiple sclerosis [0.03%]
克拉屈滨治疗多发性硬化的药物评价叙事综述
Sarah-Jane Martin,Shane Arsenault,Jiwon Oh
Sarah-Jane Martin
Multiple sclerosis [MS] is an immune-mediated disease driven by peripherally mediated and central nervous system compartmentalized pathophysiologic processes. Major advances have led to a plethora of disease modifying therapies [DMTs] avail...
Multiple sclerosis as a genetic risk factor for Alzheimer's disease: Insights from Mendelian randomisation [0.03%]
遗传性多发性硬化与阿尔茨海默病的关联：孟德尔随机化研究提供新见解
Jai Kumar Rajavoor Muniswamy,Amrutha Reshi,Dibyendu Roy Chowdhury et al.
Jai Kumar Rajavoor Muniswamy et al.
Background: Inflammation is implicated in neurodegeneration, but the causal link between multiple sclerosis and Alzheimer's disease remains unclear. Objec...
Outcomes of older patients with multiple sclerosis treated with interferon beta-1a or peginterferon beta-1a in MS PATHS [0.03%]
MS PATHS研究中复发型多发性硬化患者使用重组人干扰素β-1a或聚乙二醇干扰素β-1a治疗的结局：一项倾向评分匹配分析
Le H Hua,Carrie M Hersh,Lana Zhovtis Ryerson et al.
Le H Hua et al.
Background: The peak prevalence of multiple sclerosis (MS) is shifting to older patients. Using real-world data, we describe outcomes among older (≥60 years) and younger patients treated with interferon beta-1a or no dis...
Recent and on-going trials for the treatment of levodopa-induced dyskinesia: a review of the clinical trial databases [0.03%]
治疗左旋多巴诱发的异动症的最近和正在进行的临床试验：对临床试验数据库的回顾性研究
Jawad Al-Kassmy,Mohammed Alsalmi,Woojin Kang et al.
Jawad Al-Kassmy et al.
L-3,4-dihydroxyphenylalanine (Levodopa)-induced dyskinesia remains a condition for which there are few therapeutic options available. Fortunately, the past 5 years have seen the completion of several clinical trials, some of which yielded p...
Fruits as a preventative strategy: exploring their role in neurodegenerative disease management [0.03%]
水果作为预防策略：探究其在神经退行性疾病管理中的作用
Bhavani Sowndharya B,Rupesh K Gautam,Mathan Muthu C M et al.
Bhavani Sowndharya B et al.
Fruits' popularity has grown due to their ability to protect against neurodegenerative illnesses and to be an important dietary component for good brain activity. This review focuses on fruits' potential for preventing such, taking into acc...
David Foxe,James Muggleton,Sau Chi Cheung et al.
David Foxe et al.
Aim: To evaluate the survival rates in well-characterized cohorts of frontotemporal dementia (FTD) subtypes - behavioral variant (bvFTD), progressive nonfluent aphasia (PNFA), and semantic dementia (SD) - and both typical...
A systematic review of the impact of transcranial electrical stimulation (TES) on cognitive dysfunction in patients with multiple sclerosis [0.03%]
经颅电刺激(TES)对多发性硬化认知障碍影响的系统综述
Mohammad Hossein Salemi,Mohammad Hossein Harirchian
Mohammad Hossein Salemi
Aim: This systematic review study aimed to evaluate the impact of TES on cognitive dysfunction in MS patients, aiming to consolidate current knowledge and explore its clinical applicability. ...